BioRestorative Therapies Inc

General ticker "BRTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $12.1M

BioRestorative Therapies Inc follows the US Stock Market performance with the rate: 10.5%.

Estimated limits based on current volatility of 2.8%: low 1.48$, high 1.57$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.08$, 3.10$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.97$, 2.78$]

Financial Metrics affecting the BRTX estimates:

  • Negative: Non-GAAP EPS, $ of -3.51 <= 0.10
  • Negative: Operating profit margin, % of -99.05 <= 1.03
  • Negative: Operating cash flow per share per price, % of -45.35 <= 2.35
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term BRTX quotes

Long-term BRTX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.05MM $0.12MM $0.15MM
Operating Expenses $26.35MM $19.09MM $15.37MM
Operating Income $-26.31MM $-18.97MM $-15.22MM
Non-Operating Income $-18.00MM $-0.02MM $4.80MM
Interest Expense $1.82MM $0.01MM $0.00MM
R&D Expense $0.73MM $3.51MM $4.03MM
Income(Loss) $-44.30MM $-18.99MM $-10.42MM
Profit(Loss) $-44.30MM $-18.99MM $-10.42MM
Stockholders Equity $21.60MM $15.83MM $10.00MM
Inventory $0.00MM $0.00MM $0.00MM
Assets $22.45MM $16.43MM $12.61MM
Operating Cash Flow $-3.33MM $-5.87MM $-6.43MM
Capital expenditure $0.03MM $0.44MM $0.17MM
Investing Cash Flow $-0.03MM $-13.48MM $3.25MM
Financing Cash Flow $21.32MM $0.00MM $2.35MM
Earnings Per Share* $-25.21 $-4.98 $-2.47

* EPS are Split Adjusted, recent splits may be reflected with a delay.